Full Press Release Details
CORPORATE PRESENTATION ex-99.1.
PCSA
CORPORATE PRESENTATION ex-99.1
Key Takeaway: CORPORATE PRESENTATION ex-99.1
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+27%
120-day peak, hindsight
Typical move
1.3%
average across 3 past catalysts
Cash runway
~0 mo
High dilution risk
Lead asset
VT7208
Phase 1 · Multiple Sclerosis